An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER21 Breast Cancers With ERBB Ligand Overexpression
Luis J. Schwarz, Katherine E. Hutchinson, Brent N. Rexer, Mónica Valeria Estrada, Paula I. Gonzalez Ericsson, Melinda E. Sanders, Teresa C. Dugger, Luigi Formisano, Angel Guerrero-Zotano, Monica Red-Brewer, Christian D. Young, Johan Lantto, Mikkel W. Pedersen, Michael Kragh, Ivan D. Horak, Carlos L. Arteaga
Dive into the research topics of 'An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER21 Breast Cancers With ERBB Ligand Overexpression'. Together they form a unique fingerprint.